GENEVA, Sept. 28 -- HANX BIOPHARMACEUTICALS, (WUHAN) LTD. (Building A8, BioPark II, Jiufeng Yi Road, Hongshan DistrictWuhan, Hubei 430073) filed a patent application (PCT/CN2025/084047) for "IMMUNOTHERAPY FOR OX40 EXPRESSING CANCER" on Mar 21, 2025. With publication no. WO/2025/195496, the details related to the patent application was published on Sep 25, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): YANG, Tao (Building A8, BioPark II, Jiufeng Yi Road, Hongshan DistrictWuhan, Hubei 430073), LI, Henry qixiang (Building A8, BioPark II, Jiufeng Yi Road, Hongshan DistrictWuhan, Hubei 430073), ...